This page includes the latest FDA filings for Intra Cellular Therapies Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | ITCI | DUNS 112765909 |
Device Company | Device | Date |
|---|---|---|
| Intra-Cellular Therapies, Inc | Prescription Medication | 2023-07-07 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2022-09-27 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2022-08-11 |
| Intra-Cellular Therapies, Inc | CAPLYTA | 2022-08-09 |
| Intra-Cellular Therapies, Inc | CAPLYTA | 2022-08-09 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2022-04-02 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2021-12-23 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2021-12-21 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2021-07-17 |
| Intra-Cellular Therapies, Inc | CAPLYTA | 2020-02-01 |
| Intra-Cellular Therapies, Inc | Prescription Medication | 2020-02-01 |
| NCAGE Code | 3CQL3 | INTRA-CELLULAR THERAPIES, INC. |
| CAGE Code | 3CQL3 | INTRA-CELLULAR THERAPIES, INC. |
| S.A.M. Registration | 3CQL3 [112765909] | INTRA-CELLULAR THERAPIES, INC. |
| DUNS | 112765909 | Intra-Cellular Therapies, Inc. |
| SEC | 0001176407 | INTRA CELLULAR THERAPIES INC of DELAWARE |
| SEC | 0001567514 | Intra-Cellular Therapies, Inc. of DELAWARE |